- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens, Epix, and Mallinckrodt join forces
Siemens Medical Systems, Epix Medical, and Mallinckrodt are teaming up to develop contrast-based cardiovascular MR imaging technologies to improve the diagnosis of atherosclerosis and related diseases. The collaboration will combine Epix and
Siemens Medical Systems, Epix Medical, and Mallinckrodt are teaming up to develop contrast-based cardiovascular MR imaging technologies to improve the diagnosis of atherosclerosis and related diseases. The collaboration will combine Epix and Mallinckrodts AngioMark intravascular MRI contrast agent with advanced imaging and 3-D visualization technologies to create enhanced MRI scanning protocols and imaging methods, according to the firms.
AngioMark is currently in a phase III clinical trial to determine the efficacy of the agent in detecting aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease or abdominal aortic aneurysm. The trial is designed to compare the diagnostic accuracy of AngioMark-enhanced MR angiography with x-ray angiography.
The nonexclusive collaboration between Siemens of Iselin, NJ, Cambridge, MA-based Epix, and Mallinckrodt of St. Louis will also focus on expanding the use of MRI in diagnosing cardiovascular disease and providing new tools to improve 3-D visualization of the cardiovascular system. Research and development will take place at both Siemens and Epix.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
